Role of cardiovascular protection played by dipeptidyl peptidase 4 inhibitors / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 79-82, 2014.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-443368
Biblioteca responsável:
WPRO
ABSTRACT
Cardiovascular disease is a common complication of type 2 diabetes,causing considerable fatality.Dipeptidyl peptidase 4 (DPP-4) inhibitors are new drugs for treatment of diabetes.Current studies have demonstrated that these drugs play an important role in cardiovascular protection.DPP-4 inhibitors can lower blood pressure,regulate blood lipid,and suppress inflammation and atherosclerosis.Treatment with DPP-4 inhibitors results in reduced size of myocardial infarct,reduced myocardial ischemia/reperfusion injury,increased myocardial cell regeneration,and improved heart function,etc.Recent studies have also found that DPP-4 inhibitors are able to mobilize progenitor cells to the sites of cardiovascular injury and thus to promote tissue repair.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Endocrinology and Metabolism
Ano de publicação:
2014
Tipo de documento:
Artigo